BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11881223)

  • 1. [Blood component transfusion in children. Current recommendations].
    Kreuger A; Akerblom O
    Lakartidningen; 2002 Feb; 99(6):502-6. PubMed ID: 11881223
    [No Abstract]   [Full Text] [Related]  

  • 2. [Infections of the gastrointestinal system--risk of transmission with blood and blood components].
    Korsak J
    Pol Merkur Lekarski; 2007 May; 22(131):502-4. PubMed ID: 17679406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward reducing perioperative transfusions.
    Joyce JA
    AANA J; 2008 Apr; 76(2):131-7. PubMed ID: 18478819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rational blood component therapy in patients with life-threatening hemorrhage].
    Johansson PI; Lethagen S; Lippert FK; Stensballe J;
    Ugeskr Laeger; 2005 Jun; 167(25-31):2753-5. PubMed ID: 16014258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force.
    Treleaven J; Gennery A; Marsh J; Norfolk D; Page L; Parker A; Saran F; Thurston J; Webb D
    Br J Haematol; 2011 Jan; 152(1):35-51. PubMed ID: 21083660
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood conservation strategies in pediatric anesthesia.
    Verma S; Eisses M; Richards M
    Anesthesiol Clin; 2009 Jun; 27(2):337-51. PubMed ID: 19703680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bibliography. Current world literature. Hematopoietic stem cell transplantation.
    Curr Opin Hematol; 2006 Nov; 13(6):496-9. PubMed ID: 17053465
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood component therapy and changing transfusion triggers.
    Williford PD; Bensky KP
    CRNA; 1994 Nov; 5(4):139-50. PubMed ID: 7881351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric transfusion.
    New HV
    Vox Sang; 2006 Jan; 90(1):1-9. PubMed ID: 16359350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfusion of blood and products derived from blood].
    Wautier JL
    Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood component therapy.
    Fasano R; Luban NL
    Pediatr Clin North Am; 2008 Apr; 55(2):421-45, ix. PubMed ID: 18381094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transfusion related graft versus host disease. Indications for irradiated blood components].
    Muñiz-Díaz E; Martínez Valverde C; Sierra J; Madoz P
    Sangre (Barc); 1999 Dec; 44(6):483-8. PubMed ID: 10822764
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Practice guidelines for blood component therapy' summarized.
    Weiskopf RB
    West J Med; 1997 Mar; 166(3):204-5. PubMed ID: 9143200
    [No Abstract]   [Full Text] [Related]  

  • 14. Three reported cases of variant Creutzfeldt-Jakob disease transmission following transfusion of labile blood components.
    Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
    Vox Sang; 2006 Nov; 91(4):348. PubMed ID: 17105612
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines.
    Josephson CD; Su LL; Hillyer KL; Hillyer CD
    Transfus Med Rev; 2007 Apr; 21(2):118-33. PubMed ID: 17397762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukocyte depletion of blood products. Indications and technical implementation].
    Böck M; Heim MU
    Fortschr Med; 1995 Mar; 113(8):102-4. PubMed ID: 7759031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-transmitted bacterial infection: risks, sources and interventions.
    Wagner SJ
    Vox Sang; 2004 Apr; 86(3):157-63. PubMed ID: 15078249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicians as gatekeepers: what is the best route to optimal blood use?
    Isbister JP
    Dev Biol (Basel); 2007; 127():9-14. PubMed ID: 17486878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries].
    Andersen O
    Lakartidningen; 2002 Mar; 99(12):1310-4. PubMed ID: 11998162
    [No Abstract]   [Full Text] [Related]  

  • 20. Residual immunological risks associated with red blood cell transfusion.
    Rouger P; Le Pennec PY
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):217-9. PubMed ID: 8337131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.